Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 30, Issue 4, April 2005, Pages 333-434
 
MONOGRAPHS
 
  
 ERB-041.
Estrogen receptor (ER) β agonist, Treatment of endometriosis, Treatment of rheumatoid arthritis.
Malamas, M.S., Keith, J.C. Jr., Harris, H.A.
Drugs Fut 2005, 30(4): 333
Summary | Full Text: HTMLPDF 
 
  
  
 MK-0431.
Agent for type 2 diabetes, Dipeptidyl-peptidase IV (CD26) inhibitor.
Sorbera, L.A., Castaner, J.
Drugs Fut 2005, 30(4): 337
Summary | Full Text: HTMLPDF 
 
  
  
 Torcetrapib.
Atherosclerosis therapy, Cholesteryl ester transfer protein (CETP) inhibitor.
McIntyre, J.A., Castaner, J.
Drugs Fut 2005, 30(4): 344
Summary | Full Text: HTMLPDF 
 
  
 
REVIEW ARTICLES
 
  
 A novel approach to anticancer therapies for prostate cancer: lipoxygenase as a new target in the treatment of prostate cancer.
Yoshimura, R., Matsuyama, M., Kuratsukuri, K., Tsuchida, K., Takemoto, Y., Nakatani, T.
Drugs Fut 2005, 30(4): 351
Summary | Full Text: HTMLPDF 
 
  
  
 HIV gp120 envelope as a therapeutic target.
Wang, H.H., Kadow, J., Lin, P.
Drugs Fut 2005, 30(4): 359
Summary | Full Text: HTMLPDF 
 
  
 
Annual Update 2004/2005
 
  
 Treatment of cardiovascular disorders.
N.E. Mealy, M. Bayés
Drugs Fut 2005, 30(4): 369
Summary | Full Text: HTMLPDF 
 
  
 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy